Adaptive Biotechnologies ADPT Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Plus components not separately reported this period.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's total debt?
- Adaptive Biotechnologies (ADPT) reported total debt of $208.18M in Q1 2026.
- How has Adaptive Biotechnologies's total debt changed year-over-year?
- Adaptive Biotechnologies's total debt decreased by 5.6% year-over-year, from $220.46M to $208.18M.
- What is the long-term trend for Adaptive Biotechnologies's total debt?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's total debt has grown at a 14.3% compound annual growth rate (CAGR), from $107.86M to $210.36M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.